Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients
Clinical trial NCT01646268 · COMPLETED
Trial details
- NCT number
- NCT01646268
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.